Ketamin Abcur (Ketamine)

Ketamine acts primarily by blocking NMDA receptors in the brain, reducing excitatory glutamate signaling. This blockade produces a dissociative state, leading to loss of consciousness, analgesia, and sedation. Additional effects on opioid receptors and catecholamine release contribute to its cardiovascular profile.

Dosing of ketamine is individualized and determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and the intended use (e.g., induction, analgesia, or sedation). Specific regimens are not provided here and should follow local practice guidelines.

The safety of ketamine during pregnancy and lactation has not been definitively established. It is classified as having an unknown pregnancy category, and clinicians generally exercise caution, weighing potential benefits against possible risks before use in pregnant or nursing patients.

To request Ketamin Abcur, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Ketamine differs from agents such as propofol or volatile anesthetics by providing dissociative anesthesia and preserving airway reflexes, while also stimulating cardiovascular output. Compared with other NMDA antagonists like esketamine, ketamine is the racemic mixture and may have a broader side‑effect profile, but both share similar mechanisms of action.

Ketamin Abcur should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the vials from direct light, moisture, and extreme temperature fluctuations. Do not freeze the product, and ensure that any unused solution is discarded according to local regulations.

Ketamin Abcur is supplied as a sterile injectable solution for intramuscular (IM) or intravenous (IV) administration. The route, rate, and total dose are determined by the treating clinician, who may use a bolus injection followed by an infusion or titrate the dose to achieve the desired depth of anesthesia or sedation.

Serious adverse events include respiratory depression, severe hypertension, cardiac arrhythmias, and rare neurotoxic effects with high or repeated dosing. Clinicians should monitor airway patency, cardiovascular status, and neurological signs throughout the procedure and be prepared to intervene promptly if complications arise.

Ketamin Abcur is contraindicated in patients with known hypersensitivity to ketamine or its excipients, those with uncontrolled hypertension, severe cardiovascular disease, or a history of psychosis such as schizophrenia. Caution is also advised for patients with elevated intracranial pressure or significant liver dysfunction.